Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Zenith Healthcare Ltd
Your Vote -
Buy
84.72%
Hold
6.94%
Sell
8.33%
84.72%
72 users have voted
Option Chain
Analyzes market sentiment, predicts Zenith Healthcare Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Zenith Healthcare - Board Meeting Intimation for Board Meeting Intimation For Considering The Un-Audited Financial Results F
-
Zenith Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2025
-
Zenith Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Zenith Healthcare - Appointment Of Secretarial Auditor Of The Company
-
Zenith Healthcare - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Zenith Healthcare - Proceedings Of 31St Annual General Meeting Held On 30Th September, 2025
-
Zenith Healthcare - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Zenith Healthcare - Reg. 34 (1) Annual Report.
-
Zenith Healthcare - Record Date Fixation For E-Voting For Ensuing AGM
-
Zenith Healthcare - Notice Of 31St Annual General Meeting Of The Company
-
Zenith Healthcare - Book Closure Notice For 31St Annual General Meeting (AGM).
-
Zenith Healthcare - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On 01St September, 2025
-
Zenith Healthcare - Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Monday, September 01, 2025
-
Zenith Healthcare posts Q1 net loss of Rs 0.02 cr
-
Zenith Healthcare - Financial Result
-
Zenith Healthcare - Board Meeting Outcome for Outcome Of The Meeting Of Board Of Directors Held On 12Th August, 2025
Key fundamentals
Evaluate the intrinsic value of Zenith Healthcare Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 7.4062 | 7.3378 | 7.2321 | 7.1543 | 6.8436 |
| Liabilities | 7.4062 | 7.3378 | 7.2321 | 7.1543 | 6.8436 |
| Equity | 5.3739 | 5.3739 | 5.3739 | 5.3739 | 5.3739 |
| Gross Profit | 0.092 | 0.2294 | 0.0297 | 0.4592 | 0.3565 |
| Net Profit | 0.067 | 0.2035 | 0.0778 | 0.3106 | 0.4399 |
| Cash From Operating Activities | 0.6744 | 1.7361 | -0.9247 | 1.3174 | -1.465 |
| NPM(%) | 0.59 | 1.4 | 0.59 | 1.38 | 3.2 |
| Revenue | 11.3297 | 14.4717 | 13.1294 | 22.3618 | 13.7398 |
| Expenses | 11.2377 | 14.2423 | 13.0997 | 21.9026 | 13.3833 |
| ROE(%) | 0.9 | 2.74 | 1.05 | 4.19 | 5.94 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Zenith Healthcare Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 851.70 | -2.84 | 77.71 | 2.23 | 301.39 | 0.58 |
| Lotus Eye Hospital and Institute Ltd | 120.75 | -1.23 | 391.06 | 8.11 | 3.55 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 20.25 | -0.10 | 0.00 | 16.84 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 634.95 | -1.26 | 0.00 | 7.65 | -604.77 | 0.00 |
Company Info
The company was incorporated on 15.11.1994 under the Companies Act, 1956 and Registered with the Registrar of Companies, Gujarat at Ahmedabad. It has obtained Certificate of Commencement of Business on 21.11.1994. The company has started implementation of the project and have already deployed Rs.170.85 lacs upto 22.02.1995 in acquisition of Land and towards advances for building and plant and machinery. The main object of the company are fully set out in the Memorandum of Association of the company as stated elsewhere in the Prospectus. The immediate object of the company is to set up facilities for the manufacturing of Tablets (Alopethic & Ayurvedic), Capsules, Ointments, Liquid Injectable etc. The proposed project will be located at Plot No..388/34 Changodar Industrial Estate, Changodar, Taluka Sanand, District: Ahmedabad, Gujarat, a notified category-II backward area eligible for subsidy and sales tax benefits. 2005 -Company has splits its Face value of Shares from Rs 10 to Re 1.
The company was incorporated on 15.11.1994 under the Companies Act, 1956 and Registered with the Registrar of Companies, Gujarat at Ahmedabad. It has obtained Certificate of Commencement of Business on 21.11.1994. The company has started implementation of the project and have already deployed Rs.170.85 lacs upto 22.02.1995 in acquisition of Land and towards advances for building and plant and machinery. The main object of the company are fully set out in the Memorandum of Association of the company as stated elsewhere in the Prospectus. The immediate object of the company is to set up facilities for the manufacturing of Tablets (Alopethic & Ayurvedic), Capsules, Ointments, Liquid Injectable etc. The proposed project will be located at Plot No..388/34 Changodar Industrial Estate, Changodar, Taluka Sanand, District: Ahmedabad, Gujarat, a notified category-II backward area eligible for subsidy and sales tax benefits. 2005 -Company has splits its Face value of Shares from Rs 10 to Re 1.
Read More
Parent Organisation
Zenith Healthcare Ltd.
Founded
15/11/1994
Managing Director
Mr.Mahendra Raycha
NSE Symbol
FAQ
The current price of Zenith Healthcare Ltd is
The 52-week high for Zenith Healthcare Ltd is
The market capitalization of Zenith Healthcare Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Zenith Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Zenith Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Zenith Healthcare Ltd shares.
The CEO of Zenith Healthcare Ltd is Mr.Mahendra Raycha, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
